02_01 An Overview of Considerations for Early Breast Cancer

Talking About Tumors with Ryann and Ryan - A medical oncology podcast

1. History of surgery and radiation for breast cancer

2. Indication and goal of adjuvant systemic therapy (incl cell-kill hypothesis)

3. Overview of breast cancer subtypes

4. Strategies and guidelines for surveillance

Citations

As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations at your region of training.

DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. 10th edition. Philadelphia: Wolters Kluwer, 2015.

Uptodate.com Waltham, MA: Wolters Kluwer.

Some highlighted references recommended to read related to this specific episode:

1. Bonadonna G, et al. N Engl J Med. 1976;294(8):405-410. doi:10.1056/NEJM197602192940801

2. Giuliano AE, et al. JAMA. 2017;318(10):918-926. doi:10.1001/JAMA.2017.11470

3. Abe O et al. Lancet. 2005;365(9472):1687-1717. doi:10.1016/S0140-6736(05)66544-0

4. Albain K et al. The Lancet. 2012;379(9814):432-444. doi:10.1016/S0140-6736(11)61625-5

5. Asselain B et al. Lancet Oncol. 2018;19(1):27-39. doi:10.1016/S1470-2045(17)30777-5

6. Predict Breast. Accessed September 25, 2022. https://breast.predict.nhs.uk/

7. Masuda N et al. NEJM. 2017;376(22):2147-2159. doi:10.1056/NEJMOA1612645

8. Berruti A et al J Clin Oncol. 2014;32(34):3883-3891. doi:10.1200/JCO.2014.55.2836

9. von Minckwitz G et al. J Clin Oncol. 2012;30(15):1796-1804. doi:10.1200/JCO.2011.38.8595

10. Henry NL et al. J Clin Oncol. 2019;37(22):1965-1977. doi:10.1200/JCO.19.00948

11. von Minckwitz G et al. NEJM. 2019;380(7):617-628. doi:10.1056/NEJMOA1814017/

12. Mukherjee Siddhartha. The emperor of all maladies : a biography of cancer. Published 2010.

13. Harris LN et al. J Clin Oncol. 2016;34(10):1134-1150. doi:10.1200/JCO.2015.65.2289

Disclosures

Talking about Tumors with Ryan and Ryann is not medical advice. We have received no funding in relation to the information discussed within this episode and have no financial conflicts of interest to disclose. All opinions are those of whoever stated them. We have compiled this podcast to serve as an introduction to the field of medical oncology for post-graduate trainees interested in the topic.

Tags

Hematology/Oncology, evidence based medicine, education, chemotherapy, immunotherapy, medical oncology